29 results on '"Yoshifumi Tada"'
Search Results
2. Overlapping rheumatoid meningitis with anti‐N‐methyl‐D‐aspartate receptor encephalitis: A case report
- Author
-
Toshihiro Ide, Takeru Kawanami, Yoshifumi Tada, and Makoto Eriguchi
- Subjects
anti‐N‐methyl‐D‐aspartate receptor encephalitis ,intravenous immunoglobulin ,intravenous methylprednisolone ,rheumatoid arthritis ,rheumatoid meningitis ,Medicine ,Medicine (General) ,R5-920 - Abstract
Abstract A 66‐year‐old woman in treatment for rheumatoid meningitis was found to be positive for anti‐N‐methyl‐D‐aspartate receptor (NMDAR) antibodies in the cerebrospinal fluid, and intravenous immunoglobulin improved her psychiatric symptoms. The co‐existence of NMDAR antibodies should be considered in cases of poor response to treatments or atypical symptoms in rheumatoid meningitis.
- Published
- 2023
- Full Text
- View/download PDF
3. Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders
- Author
-
Yoshifumi Tada, Akira Maeyama, Tomonobu Hagio, Mariko Sakai, Akihito Maruyama, and Takuaki Yamamoto
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Lymphoproliferative disorders (LPDs) are serious complications associated with rheumatoid arthritis (RA) treatment that mostly occur during methotrexate (MTX) treatment. Cessation of MTX may induce regression of LPDs but is often followed by a flare of RA. Here, we describe two patients with RA flares after the discontinuation of MTX due to LPDs and sarilumab was useful for the treatment of RA without a relapse of LPDs. Patient 1 was an 84-year-old woman, who developed an LPD in the pharyngeal region after 7 years of MTX treatment. Discontinuation of MTX induced regression of LPD but RA flared within 6 months. Administration of sarilumab, in addition to salazosulfapyridine and prednisolone, reduced the RA activity without LPD relapse. Patient 2 was a 76-year-old man, who developed LPD in the pharyngeal region after 5 years of MTX treatment. Discontinuation of MTX induced regression of LPD, but soon RA flared. Although treatment with tocilizumab (TCZ) was effective in controlling RA, it flared again after 2 years. TCZ was switched to sarilumab and RA was in remission. LPD did not recur during these periods.
- Published
- 2023
- Full Text
- View/download PDF
4. Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan
- Author
-
Shin-ya Kawashiri, Yushiro Endo, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Toshiyuki Aramaki, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Shuji Nagano, Yoshifumi Tada, and Atsushi Kawakami
- Subjects
Rheumatoid arthritis ,Musculoskeletal ultrasound ,Abatacept ,Dickkopf-1 ,Osteoprotegerin ,Power Doppler ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background To evaluate the effect of treatment on serum bone biomarkers and explore whether serum bone biomarkers are associated with therapeutic response in rheumatoid arthritis (RA) patients treated with abatacept. Methods We enrolled 59 RA patients treated with abatacept from a multicenter, exploratory, short-term, prospective and observational ultrasound cohort study of patients who received biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) therapy. We evaluated the patients’ clinical disease activity and musculoskeletal ultrasound (MSUS) scores. The serum concentrations of five bone biomarkers were evaluated (dickkopf-1 [Dkk-1], sclerostin [SOST], osteocalcin [OC], osteopontin [OPN], and osteoprotegerin [OPG]) by multiplex bead assays at baseline, 3, and 6 months: the change over 6 months was defined as the Δ value. ‘Power Doppler (PD) responder’ was defined as a patient whose Δtotal PD score over 6 months was greater than the median change. Results Abatacept significantly improved the clinical disease activity and MSUS score over 6 months. Serum OPG was significantly elevated at 6 months after the abatacept introduction (p = 0.016). The ΔSOST and ΔOPG were significantly greater in the PD responders versus the non-PD responders (p = 0.0041 and 0.0073, respectively). The serum Dkk-1 at baseline was significantly lower in the PD responders (n = 30) vs. the non-PD responders (n = 29) (p = 0.026). A multivariate logistic regression analysis showed that the serum Dkk-1 at baseline (odds ratio 0.50, 95% confidence interval [CI] 0.23–0.91, p = 0.043) was an independent predictor of PD responder status. Conclusion Serum levels of bone biomarkers may be useful for predicting RA patients’ therapeutic responses to abatacept. Trial registration Name of the registry: Assessment of therapeutic responsiveness by imaging of the joints in patients with rheumatoid arthritis; A observational cohort study Trial registration number: UMIN000012524 Date of registration: 12/9/2013 URL of trial registry record: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000014657
- Published
- 2021
- Full Text
- View/download PDF
5. Development of a rapid scabies immunodiagnostic assay based on transcriptomic analysis of Sarcoptes scabiei var. nyctereutis
- Author
-
Teruo Akuta, Daisuke Minegishi, Nobuhide Kido, Keitaro Imaizumi, Shinji Nakaoka, Shin-Ichiro Tachibana, Kenji Hikosaka, Fumi Hori, Masataka, Nakagawa, Chiaki Sakuma, Yuki Oouchi, Yu Nakajima, Sohei Tanaka, Tomoko Omiya, Kouki Morikaku, Minori Kawahara, Yoshifumi Tada, Hiroshi Tarui, Takafumi Ueda, Takane Kikuchi-Ueda, and Yasuo Ono
- Subjects
Medicine ,Science - Abstract
Abstract Scabies is a highly contagious skin disease caused by the mite Sarcoptes scabiei that affects many mammals. However, the sensitivity of traditional tests for scabies diagnosis in humans is less than 50%. To simplify the diagnosis of scabies, methods that are simple, sensitive, specific, and cost-effective are required. We developed an immunodiagnostic test based on S. scabiei var. nyctereutis RNA-seq data collected from Japanese raccoon dogs with sarcoptic mange. Three candidate antigens—a highly expressed hypothetical protein “QR98_0091190,” another mite allergen known as “SMIPP-Cc,” and an abundant “vitellogenin-like protein”—were evaluated by western-blot analysis. A lateral flow immunoassay, using specific antibodies against the vitellogenin-like protein, successfully detected scabies in the skin flakes of S. scabiei-infected raccoon dogs. This assay can potentially diagnose scabies more accurately in wildlife, as well as in humans.
- Published
- 2021
- Full Text
- View/download PDF
6. Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan
- Author
-
Yushiro Endo, Shin-ya Kawashiri, Shimpei Morimoto, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Tomomi Tsuru, Shuji Nagano, Yojiro Arinobu, Toshihiko Hidaka, Yoshifumi Tada, and Atsushi Kawakami
- Subjects
rheumatoid arthritis ,doppler ultrasonography ,tumour necrosis factor inhibitor ,non-tumour necrosis factor inhibitor ,retention ,Immunologic diseases. Allergy ,RC581-607 - Abstract
To compare therapeutic efficacy of tumour necrosis factor inhibitor (TNFi) cyclers and non-TNFi switchers in patients with rheumatoid arthritis (RA) having inadequate response to previous TNFis (TNF-IR patients) using composite measures including imaging assessment with power Doppler ultrasonography (PDUS). Patients with RA who had inadequate response to one or more previous TNFi agents with moderate or higher disease activity were enrolled. The outcomes of 56 TNF-IR patients were analysed. Patients were divided into 19 TNFi cyclers and 37 non-TNFi switchers (16 abatacept [ABT] and 21 tocilizumab [TCZ] switchers). Retention ratio at 6 months was significantly higher in non-TNFi switchers than in TNFi cyclers (p
- Published
- 2020
- Full Text
- View/download PDF
7. Immediate Effect of Baricitinib on Arthritis and Biological Disease-Modifying Antirheumatic Drug-Induced Psoriasis-Like Skin Lesions in Two Patients with Rheumatoid Arthritis
- Author
-
Yoshifumi Tada, Nobuyuki Ono, and Syuichi Koarada
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Biological disease-modifying antirheumatic drugs (bDMARDs) are very effective for treating rheumatoid arthritis (RA). However, they sometimes induce adverse events such as psoriasis-like skin lesions. We describe psoriasis-like skin lesions that developed simultaneously with an RA flare in patient 1 during treatment with abatacept and in patient 2 soon after starting certolizumab pegol. The skin lesions persisted in patient 2 despite stopping certolizumab. Baricitinib was initiated because of RA flare and resulted in immediate beneficial effects on arthritis as well as skin lesions. The RA went into remission in both patients, and the psoriasis-like skin lesions disappeared within four weeks (patient 1) and three months (patient 2).
- Published
- 2021
- Full Text
- View/download PDF
8. Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
- Author
-
Syuichi Koarada, Masahiko Tsuboi, Mitsunori Komine, Yoshinobu Nakao, Yukiko Tokuda, Yukihide Ono, Satoko Tashiro, Akihito Maruyama, Nobuyuki Ono, Akihide Ohta, and Yoshifumi Tada
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
We report four cases of successful treatment with certolizumab pegol (CZP) of rheumatoid arthritis (RA) patients with persistent inflamed residual mono- or oligosynovitis resistant to prior TNF-α inhibitors. Although the patients were in a moderate disease activity, a low activity, or a remission of RA, they sustained inflammatory mono-/oligoarthritis even after treatment with prior TNF inhibitors. They were then all treated with CZP and observed in a serial ultrasonography. In all cases, the positive power Doppler signals in the joint have disappeared promptly and all of the patients were able to retain remission in the long term. The treatment of CZP to the refractory mono-/oligoarthritis of inflammatory synovitis in RA patients has not been previously described. The cases suggest that it may be associated with the feature of CZP, possible effective penetration into the site of inflammation.
- Published
- 2015
- Full Text
- View/download PDF
9. Load-Deflection and Friction Properties of PEEK Wires as Alternative Orthodontic Wires
- Author
-
Yoshifumi Tada, Tohru Hayakawa, and Yoshiki Nakamura
- Subjects
orthodontic wire ,PEEK ,static friction ,load deflection ,three-point bending ,Technology ,Electrical engineering. Electronics. Nuclear engineering ,TK1-9971 ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Microscopy ,QH201-278.5 ,Descriptive and experimental mechanics ,QC120-168.85 - Abstract
Polyetheretherketone (PEEK) is now attracting attention as an alternative to metal alloys in the dental field. In the present study, we evaluated the load-deflection characteristics of PEEK wires in addition to their frictional properties. Three types of PEEK wires are used: two sizes of rectangular shape, 0.016 × 0.022 in2 and 0.019 × 0.025 in2 (19-25PEEK), and rounded shape, diameter 0.016 in (16PEEK). As a control, Ni-Ti orthodontic wire, diameter 0.016 in, was used. The three-point bending properties were evaluated in a modified three-point bending system for orthodontics. The static friction between the orthodontic wire and the bracket was also measured. The load-deflection curves were similar among Ni-Ti and PEEK wires, except for 16PEEK with slot-lid ligation. The bending force of 19-25PEEK wire was comparable with that of Ni-Ti wire. 19-25PEEK showed the highest load at the deflection of 1500 μm (p < 0.05) in the case of slot-lid ligation. No significant differences were seen in the permanent deformation between Ni-Ti and all three PEEK wires (p > 0.05). No significant difference was seen in static friction between all three PEEK wires and Ni-Ti wire (p > 0.05). It is suggested that 19-25PEEK will be applicable for orthodontic treatment with the use of slot-lid ligation.
- Published
- 2017
- Full Text
- View/download PDF
10. RP105-Negative B Cells in Systemic Lupus Erythematosus
- Author
-
Syuichi Koarada and Yoshifumi Tada
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Abstract
Systemic lupus erythematosus (SLE) is a multisystem disease characterized by B cells producing autoantibodies against nuclear proteins and DNA, especially anti-double-strand DNA (dsDNA) antibodies. RP105 (CD180), the toll-like receptor- (TLR-) associated molecule, is expressed on normal B cells. However, RP105-negative B cells increase in peripheral blood from patients with active SLE. RP105 may regulate B-cell activation, and RP105-negative B cells produce autoantibodies and take part in pathophysiology of SLE. It is possible that targeting RP105-negative B cells is one of the treatments of SLE. In this paper, we discuss the RP105 biology and clinical significance in SLE.
- Published
- 2012
- Full Text
- View/download PDF
11. Phenotyping of P105-Negative B Cell Subsets in Patients with Systemic Lupus Erythematosus
- Author
-
Syuichi Koarada, Yoshifumi Tada, Rie Suematsu, Sachiko Soejima, Hisako Inoue, Akihide Ohta, and Kohei Nagasawa
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Abstract
This study aimed to investigate phenotype of RP105(−) B cell subsets in patients with systemic lupus erythematosus (SLE). Flow cytometry was used for phenotyping RP105-negaive B cell subsets. Based on CD19, RP105, and CD138 expression, RP105(−) B cells consist of at least 5 subsets of late B cells, including CD19(+)RP105(int), CD19(+) RP105(−), CD19(low) RP105(−) CD138(−), CD19(low) RP105(−)CD138(int), and CD19(low) RP105(−) CD138(++) B cells. Especially, CD19(+)RP105(int) and CD19(low) RP105(−)CD138(int) B cells are significantly larger than other RP105(−) B cell subsets in SLE. By comparison of RP105(−) B cell subsets between patients with SLE and normal subjects, these subsets were detectable even in normal subjects, but the percentages of RP105(−) B cell subsets were significantly larger in SLE. The phenotypic analysis of RP105(−) B cell subsets suggests dysregulation of later B cell subsets in SLE and may provide new insights into understanding regulation of B cells in human SLE.
- Published
- 2012
- Full Text
- View/download PDF
12. Relationships between Type 1 interferon signatures and clinical features of the new-onset lupus patients in Japan.
- Author
-
Yuri Shirahama, Aki Hashimoto, Nobuyuki Ono, Yukiko Takeyama, Akihito Maruyama, Takuya Inoue, Yoshifumi Tada, and Hiroaki Niiro
- Subjects
TYPE I interferons ,LEUCOCYTES ,SYSTEMIC lupus erythematosus ,HOSPITAL admission & discharge ,DNA antibodies - Abstract
Objectives: The objective of the study is to investigate the relationships between Type 1 interferon (T1-IFN) signatures and clinical characteristics of lupus patients. Methods: We examined 49 new-onset lupus patients who were diagnosed between 1999 and 2017. The patients treated with >10 mg of prednisolone or hydroxychloroquine were excluded from this study. Serum T1-IFN signatures were revealed by a functional reporter assay and standardized by recombinant IFN-α. Patient backgrounds, clinical findings, and treatments were retrospectively extracted from their electrical medical records. Clinical data were also available, including SLE Disease Activity Index of SLE patients on admission. Results: T1-IFN signatures of lupus patients closely correlated with lupus disease activities, such as SLE Disease Activity Index-2K, white blood cell, C3 levels, and the titre of double-strand DNA antibody. We found fever and acute lupus dermatitis closely associated with T1-IFN signature. Conclusions: In lupus patients, fever and acute lupus dermatitis are good indicators of a strong T1-IFN signature. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Usefulness of the severity classification for predicting drug-free remission in Japanese patients with adult-onset Still's disease.
- Author
-
Akihito Maruyama, Ayako Kokuzawa, Yusuke Yamauchi, Yohei Kirino, Hideto Nagai, Yasushi Inoue, Toshiyuki Ota, Yutaka Chifu, Satomi Inokuchi, Hiroki Mitoma, Mitsuteru Akahoshi, Mariko Sakai, Akihide Ohta, Masahiro Iwamoto, and Yoshifumi Tada
- Subjects
STILL'S disease ,JAPANESE people - Abstract
Objectives: To investigate the usefulness of severity classification for predicting outcomes in patients with adult-onset Still's disease (AOSD). Methods: This was a multi-centre retrospective cohort study. AOSD patients were classified into mild, moderate, and severe groups based on severity classification (Japanese Ministry of Health, Labour and Welfare) during the initial treatment, and clinical features were compared among these groups. The primary endpoints were the AOSD-related mortality and drug-free remission rate. For comparison, the same analysis was performed in parallel for patient groups stratified by the modified Pouchot systemic score. Results: According to severity classification, 49 (35%), 37 (26%), and 56 patients (39%) were classified into mild, moderate, and severe groups, respectively. Patients in the severe group showed higher frequency of severe complications and the use of biological agents. Although AOSDrelated survival was not significantly different (p=.0776), four of the five fatal cases were classified into the severe group. The severe group showed a reduced rate of drug-free remission (p=.0125). Patient groups classified by systemic score did not correlate with survival or drug-free remission. Conclusions: Severity classification is useful for predicting outcomes in patients with AOSD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Clinical features of elderly-onset Adult-onset Still's disease.
- Author
-
Akihito Maruyama, Ayako Kokuzawa, Yusuke Yamauchi, Yohei Kirino, Hideto Nagai, Yasushi Inoue, Toshiyuki Ota, Yutaka Chifu, Satomi Inokuchi, Syuichi Koarada, Akihide Ohta, Masahiro Iwamoto, and Yoshifumi Tada
- Subjects
STILL'S disease ,DISEASE remission ,OLDER people ,DISEASE complications ,PROGNOSIS - Abstract
Objectives: To clarify the characteristics of patients with elderly-onset Adult-onset Still's disease (AOSD). Methods: Patients were classified into elderly-onset (>60 years: 47 patients) and younger-onset (>60 years: 95 patients) groups according to their age at diagnosis of AOSD. Clinical features, treatments, and prognosis were compared between the elderly-onset and younger-onset groups. Results: In the elderly-onset group, compared with the younger-onset group, typical skin rashes were less frequent (21.3% vs 58.9%, respectively; p<.0001), whereas pleuritis (27.7% vs 7.4%, respectively; p=.0011) and disseminated intravascular coagulation (19.1% vs 2.1%, respectively; p=.0004) were more frequent, and serum ferritin levels were higher (median 12,700 ng/ml vs 2526 ng/ml, respectively; p<.0001). Overall survival and AOSD-related survival were reduced (p=.0006 and p=.0023, respectively) and drug-free remission was less frequent (p=.0035) in the elderly-onset group compared with the younger-onset group. Conclusions: Our results demonstrated that elderly-onset AOSD patients had several characteristics that differed from younger-onset AOSD patients, including less typical skin lesions, more AOSD-related complications, higher ferritin levels, and poorer prognoses. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Rosai-Dorfman Disease Presenting with Knee Arthralgia.
- Author
-
Akihito Maruyama, Arisa Ibi, Yuki Sato, and Yoshifumi Tada
- Published
- 2024
- Full Text
- View/download PDF
16. The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
- Author
-
Nobuyuki Ono, Yasushi Inoue, Tomoya Miyamura, Naoyasu Ueda, Shuji Nagano, Hisako Inoue, Kensuke Oryoji, Shun-ichiro Ota, Takuya Sawabe, Seiji Yoshizawa, Yukiko Takeyama, Yuri Sadanaga, Ayako Takamori, Yasutaka Kimoto, Katsuhisa Miyake, Takahiko Horiuchi, Hitoshi Nakashima, Hiroaki Niiro, Yoshifumi Tada, and Ono, Nobuyuki
- Published
- 2021
- Full Text
- View/download PDF
17. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
- Author
-
Yohei Kirino, Yasushi Kawaguchi, Yoshifumi Tada, Hiroshi Tsukamoto, Toshiyuki Ota, Masahiro Iwamoto, Hiroki Takahashi, Kohei Nagasawa, Shuji Takei, Takahiko Horiuchi, Hisae Ichida, Seiji Minota, Atsuhisa Ueda, Akihide Ohta, and Yoshiaki Ishigatsubo
- Subjects
HEME oxygenase ,MONOCYTES ,STILL'S disease ,FERRITIN ,IRON deficiency anemia - Abstract
Background: Heme oxygenase (HO)-1 is a heme-degrading enzyme highly expressed in monocyte/macrophage, serum levels of which may be promising biomarker for adult-onset Still's disease (AOSD). We here report data on the use of serum ferritin and HO-1 levels in AOSD. Methods: Under the Hypercytokinemia Study Group collaboration, we collected sera from a total of 145 AOSD patients. Three independent experts judged whether the patients were definite AOSD depending on the clinical information. These 91 'definite AOSD' patients were further divided into active, remission, and relapse groups. Forty-six cases of systemic vasculitis, sepsis, etc. were included as disease controls. Serum ferritin and HO-1 levels were measured using ELISA. Associations between clinical symptoms, serum ferritin, and HO-1 were explored. Multivariate regression analysis was performed to identify independent variables associated with definite AOSD diagnosis. Results: Serum ferritin and HO-1 levels were significantly higher in active and relapsed AOSD cases compared to disease controls, and were reduced by the treatment. Although a significant correlation was found between serum ferritin and HO-1 levels, a discrepancy was found in some cases such as iron-deficiency anemia. Receiver operating characteristic analysis identified optimal levels of serum ferritin (>819 ng/ml; sensitivity 76.1% and specificity 73.8%), and serum HO-1 (>30.2 ng/ml; sensitivity 84.8% and specificity 83.3%) that differentiated AOSD from controls. Interestingly, 88.9% of patients with AOSD who relapsed exceeded the cut-off value of serum HO-1 > 30.2 ng/ml, but only 50.0% exceeded serum ferritin >819 ng/ml (p = .013), suggesting that serum HO-1 levels may be a convenient indicator of AOSD disease status. Multivariate analysis identified neutrophilia, RF/ANA negativity, sore throat, and elevated serum HO-1 as independent variables associated with AOSD diagnosis. Conclusion: We confirmed that serum ferritin and HO-1 serve as highly specific and sensitive biomarkers for AOSD. A future prospective study with large sample size is necessary to determine whether these biomarkers could be included in Yamaguchi's Criteria. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
18. Successful golimumab therapy in four patients with refractory Takayasu's arteritis.
- Author
-
Rie Suematsu, Satoko Tashiro, Nobuyuki Ono, Syuichi Koarada, Akihide Ohta, and Yoshifumi Tada
- Subjects
GOLIMUMAB ,TAKAYASU arteritis ,IMMUNOSUPPRESSIVE agents ,TUMOR necrosis factors ,WOMEN'S health - Abstract
Recent studies suggested that anti-TNF-α biological therapies are effective in treating Takayasu's arteritis (TA) refractory to conventional immunosuppressive therapy. However, the efficacy of golimumab (GLM) for TA therapy is unknown. We report four women with TA who were successfully treated with GLM. GLM was prescribed as induction therapy for three patients and as maintenance therapy for one patient. GLM showed therapeutic value and might be useful, together with other anti-TNF-a agents, in treating TA. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Influence of Medical History in Parents or Siblings on the Development of Systemic Lupus Erythematosus among Japanese Females.
- Author
-
Yoshifumi Tada, Masakazu Washio, Takahiko Horiuchi, Chikako Kiyohara, Hiroki Takahashi, Gen Kobashi, Yuichiro Ide, Tatsuya Atsumi, and Toyoko Asami
- Abstract
Objective: To examine the influence of medical history in parents or siblings on the development of systemic lupus erythema-tosus (SLE) among Japanese females. Methods: 160 female SLE patients and 660 female volunteers were studied in a case-control study. Unconditional logistic regression was used to compute OR and 95% Cl, with adjustment for smoking, drinking, age and region. Results: The present study demonstrated that the risk of SLE was positively associated with family histories (i.e., medical histories in parents or siblings) of SLE (OR = 5.38, 95%CI = 1.43-20.20), rheumatoid arthritis (OR = 2.54, 95%CI = 1.08-5.96), collagen diseases (OR = 3.48, 95%CI = 1.87-6.48) and autoimmune diseases (OR = 5.25, 95%CI = 1.64-16.83). Conclusion: The result of the present study implies that common genetic and potential environmental factors among family members may lead to SLE, rheumatoid arthritis, and autoimmune diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
20. The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
- Author
-
Yoshifumi Tada, Nobuyuki Ono, Rie Suematsu, Satoko Tashiro, Yuri Sadanaga, Yukiko Tokuda, Yukihide Ono, Yoshinobu Nakao, Akihito Maruyama, Akihide Ohta, Syuichi Koarada, Tada, Yoshifumi, Ono, Nobuyuki, Suematsu, Rie, Tashiro, Satoko, Sadanaga, Yuri, Tokuda, Yukiko, Ono, Yukihide, Nakao, Yoshinobu, and Maruyama, Akihito
- Subjects
- *
SCURFIN (Protein) , *FORKHEAD transcription factors , *T cells , *TOCILIZUMAB , *ABATACEPT , *LYMPHOCYTE metabolism , *THERAPEUTIC use of monoclonal antibodies , *PROTEIN metabolism , *ANTIRHEUMATIC agents , *LYMPHOCYTES , *MONOCLONAL antibodies , *POLYMERASE chain reaction , *RHEUMATOID arthritis , *REVERSE transcriptase polymerase chain reaction , *PHARMACODYNAMICS - Abstract
Background: The balance between Th17 cells and regulatory T (Treg) cells has been shown to play an important role in the development of rheumatoid arthritis (RA). Recent studies have shown that treatment with abatacept (ABT) or tocilizumab (TCZ) affects Th17 and Treg cell populations. Although not unanimously accepted, several reports have shown that Treg cells are decreased by ABT and increased by TCZ, and that Th17 cells are decreased by TCZ. To further investigate the effects of ABT and TCZ on the skewing of T cell populations, we analyzed the expression of master regulators genes of helper T cell lineages following ABT/TCZ treatment of RA patients.Methods: Ten patients treated with ABT and 10 patients treated with TCZ were enrolled. Total RNA was extracted from peripheral blood cells at baseline, and after 12 and 24 weeks of therapy. The expression levels of T-bet, GATA3, Foxp3 and Ror-γt were semi-quantified using real-time PCR. The relative expression levels were expressed as the ratios of two genes (T-bet/GATA3, Foxp3/GATA3, Foxp3/T-bet, Foxp3/Ror-γt, Ror-γt/T-bet, Ror-γt/GATA3), and the changes in these ratios with treatment were determined.Results: The Foxp3/Ror-γt ratio was decreased after ABT therapy (0.67 ± 0.16 at 24 weeks, P = 0.0034) but was increased after TCZ therapy (2.00 ± 1.03 at 24 weeks, P = 0.0013). In addition, the Ror-γt/GATA3 ratio was decreased after TCZ therapy (0.78 ± 0.37 at 24 weeks, P = 0.0008). Except for these ratios, no significant skewing in the expression of these factors was detected. No significant relationship between clinical response to the treatment and change in the ratios of these factors was determined.Conclusion: Treatment with TCZ or ABT differently affected the balance between Foxp3 and Ror-γt expression in the peripheral blood of patients with RA. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
21. Dietary Patterns and the Risk of Systemic Lupus Erythematosus in a Japanese Population: the Kyushu Sapporo SLE (KYSS) Study.
- Author
-
Chikako Kiyohara, Masakazu Washio, Takahiko Horiuchi, Hiroki Takahashi, Yoshifumi Tada, Gen Kobashi, Toyoko Asami, Saburo Ide, and Tatsuya Atsumi
- Abstract
Background: Dietary factors are major regulators of immune function. As systemic Inpus erythematosus (SLE) is a multisystem autoimmune disorder, dietary factors are probably associated with SLE risk. However, there are very limited studies on the association between SLE risk and diet. Methods: Factor analysis of 30 food items was performed to identify dietary patterns in 125 female SLE patients and 344 female controls. Dietary information was obtained by a self-administered food frequency questionnaire. Unconditional logistic regression was used to compute the odds ratios (ORs) and their 95% confidence intervals (CIs), with adjustments for several covariates. Results: We identified three dietary patterns: vegetable, meat and dairy product patterns. After adjustment for potential confounders, the dairy product pattern was significantly associated with an increased risk of SLE. Adjusted ORs (95% CI) for SLE in the first, second, third and fourth quartiles of the dairy product pattern were 1.00 (reference), 1.76 (0.89 - 3.54), 2.25 (1.15 - 4.43) and 1.97 (0.98 - 3.95), respectively (P
trend = 0.045). The other two dietary patterns were not associated with SLE risk. Conclusion: The dairy product pattern may be associated with an increased risk of SLE. Additional studies are warranted to confirm the findings suggested in this study. [ABSTRACT FROM AUTHOR]- Published
- 2015
22. Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.
- Author
-
Atsushi Tanaka, Hiroshi Tsukamoto, Hiroki Mitoma, Chikako Kiyohara, Naoyasu Ueda, Masahiro Ayano, Shun-ichiro Ohta, Yasutaka Kimoto, Mitsuteru Akahoshi, Yojiro Arinobu, Hiroaki Niiro, Yoshifumi Tada, Takahiko Horiuchi, and Koichi Akashi
- Published
- 2015
- Full Text
- View/download PDF
23. Cigarette Smoking, Alcohol Consumption, and Risk of Systemic Lupus Erythematosus: A Case-control Study in a Japanese Population.
- Author
-
CHIKAKO KIYOHARA, MASAKAZU WASHIO, TAKAHIKO HORIUCHI, TOYOKO ASAMI, SABURO IDE, TATSUYA ATSUMI, GEN KOBASHI, YOSHIFUMI TADA, and HIROKI TAKAHASHI
- Published
- 2012
- Full Text
- View/download PDF
24. Expression of the Small Peptide GLP-1 in Transgenic Plants.
- Author
-
Hiroshi Yasuda, Yoshifumi Tada, Yuji Hayashi, Takahito Jomori, and Fumio Takaiwa
- Abstract
Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy. In order to accumulate GLP-1 in endosperm tissue of rice, a codon-optimized GLP-1 (mGLP-1) synthetic gene was directly expressed under the control of rice storage protein glutelin GluB-1 promoter in transgenic rice plants. Unexpectedly, neither the transcripts nor the transgene products were detected in the seeds of regenerated plants. Furthermore, transcripts of GluB-1 gene in these transgenic plants were not detected, and small interfering RNAs (siRNAs) corresponding to the transgene were detected. These results indicated that the expression of mGLP-1 was silenced by co-suppression in rice transgenic seeds. To avoid silencing, mGLP-1 was fused to GFP with or without self-processing 2A sequence, and introduced into rice plants. Both chimeric genes were highly expressed in these transgenic rice seeds, indicating that gene silencing could be avoided by changing the transgene components. Furthermore, the fusion protein containing the 2A sequence were processed into GFP-2A and mGLP-1 peptides with the efficiency of more than 80%, but the processed mGLP-1 peptides were not detected. Lack of accumulation of mGLP-1 may be explained by proteolytic digestion in the cytoplasm. [ABSTRACT FROM AUTHOR]
- Published
- 2005
25. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
- Author
-
Yoshifumi Tada, Syuichi Koarada, Fumitaka Morito, Osamu Ushiyama, Yoshio Haruta, Futoshi Kanegae, Akihide Ohta, Alexandra Ho, Tak W. Mak, and Kohei Nagasawa
- Subjects
- *
CELL adhesion molecules , *IMMUNOGLOBULINS , *LEUCOCYTES , *TYROSINE , *CELL migration , *LYMPHOCYTES - Abstract
Platelet endothelial cell adhesion molecule 1 (PECAM-1; CD31) is a member of the immunoglobulin superfamily that is expressed in platelets, leukocytes, and endothelial cells. PECAM-1 has been shown to play a role in transendothelial migration of leukocytes and contains immunoreceptor tyrosine-based inhibitory motifs in its cytoplasmic tail and inhibits cellular responses. We examined the role of PECAM-1 in the development of collagen-induced arthritis (CIA). CIA was induced in PECAM-1deficient DBA/1 mice. The incidence of arthritis and the arthritis index were examined. Antitype II collagen (anti-CII) antibody levels and interferon-γ (IFNγ) production by lymph node cells and spleen cells were determined. Lymphocytes from arthritic PECAM-1deficient and wild-type mice were labeled with dye, transferred to arthritic PECAM-1+/- mice, and cell migration to inflamed joints was examined. PECAM-1deficient mice showed accelerated onset of arthritis and increased severity only during the early phase. Anti-CII antibody levels were also increased during the early phase. IFNγ production by lymph node cells and spleen cells from PECAM-1deficient mice in response to CII was higher than that in wild-type mice. Lymphocytes from arthritic PECAM-1deficient mice showed accelerated migration to inflamed joints, but not lymph nodes or spleen. The development of anti-CII antibodyinduced arthritis was similar in PECAM-1deficient and wild-type mice. These results indicate that PECAM-1 negatively regulates humoral and cell-mediated immune responses and lymphocyte migration into joints and, consequently, the development of CIA. In addition, the role of PECAM-1 in the transendothelial migration of leukocytes appears to be redundant in this model. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
26. Persistent expression of CXCR5 on plasmablasts in IgG4-related disease.
- Author
-
Syuichi Koarada, Satoko Tashiro, Yukiko Tokuda, Yukihide Ono, Yuri Sadanaga, Rie Suematsu, Nobuyuki Ono, Akihide Ohta, and Yoshifumi Tada
- Published
- 2015
- Full Text
- View/download PDF
27. Subsets of RP105-negative plasmablasts in IgG4-related disease.
- Author
-
Syuichi Koarada, Satoko Tashiro, Yukiko Tokuda, Yukihide Ono, Yuri Sadanaga, Rie Suematsu, Nobuyuki Ono, Akihide Ohta, and Yoshifumi Tada
- Published
- 2014
- Full Text
- View/download PDF
28. Co-Expression of Soybean Glycinins A1aB1b and A3B4 Enhances Their Accumulation Levels in Transgenic Rice Seed.
- Author
-
Fumio Takaiwa, Chiyoko Sakuta, Seon-Kang Choi, Yoshifumi Tada, Takayasu Motoyama, and Shigeru Utsumi
- Subjects
FORAGE plants ,PLANT proteins ,SOYBEAN ,BEAN genetics - Abstract
The soybean major storage protein glycinin is encoded by five genes, which are divided into two subfamilies. Expression of A3B4 glycinin in transgenic rice seed reached about 1.5% of total seed protein, even if expressed under the control of strong endosperm-specific promoters. In contrast, expression of A1aB1b glycinin reached about 4% of total seed protein. Co-expression of the two proteins doubled accumulation levels of both A1aB1b and A3B4 glycinins. This increase can be largely accounted for by their aggregation with rice glutelins, self-assembly and inter-glycinin interactions, resulting in the enrichment of globulin and glutelin fractions and a concomitant reduction of the prolamin fraction. Immunoelectron microscopy indicated that the synthesized A1aB1b glycinin was predominantly deposited in protein body-II (PB-II) storage vacuoles, whereas A3B4 glycinin is targeted to both PB-II and endoplasmic reticulum (ER)-derived protein body-I (PB-I) storage structures. Co-expression with A1aB1b facilitated targeting of A3B4 glycinin into PB-II by sequestration with A1aB1b, resulting in an increase in the accumulation of A3B4 glycinin. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
29. Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses.
- Author
-
Rie Suematsu, Tomofumi Miyamoto, Shinobu Saijo, Sho Yamasaki, Yoshifumi Tada, Hiroki Yoshida, and Yasunobu Miyake
- Subjects
- *
LIGANDS (Biochemistry) , *LIGAND binding (Biochemistry) , *IMMUNE response , *KILLER cell receptors , *SIALIC acids , *CARDIOLIPIN - Abstract
Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of cell-surface immune receptors that bind to sialic acid at terminal glycan residues. Siglecs also recognize nonsialic acid ligands, many of which remain to be characterized. Here, we found that Siglec5 and Siglec14 recognize lipid compounds produced by Trichophyton, a fungal genus containing several pathogenic species. Biochemical approaches revealed that the Siglec ligands are fungal alkanes and triacylglycerols, an unexpected finding that prompted us to search for endogenous lipid ligands of Siglecs. Siglec5 weakly recognized several endogenous lipids, but the mitochondrial lipid cardiolipin and the anti-inflammatory lipid 5-palmitic acid-hydroxystearic acid exhibited potent ligand activity on Siglec5. Further, the hydrophobic stretch in the Siglec5 N terminus region was found to be required for efficient recognition of these lipids. Notably, this hydrophobic stretch was dispensable for recognition of sialic acid. Siglec5 inhibited cell activation upon ligand binding, and accordingly, the lipophilic ligands suppressed interleukin-8 (IL-8) production in Siglec5-expressing human monocytic cells. Siglec14 and Siglec5 have high sequence identity in the extracellular region, and Siglec14 also recognized the endogenous lipids. However, unlike Siglec5, Siglec14 transduces activating signals upon ligand recognition. Indeed, the endogenous lipids induced IL-8 production in Siglec14-expressing human monocytic cells. These results indicated that Siglec5 and Siglec14 can recognize lipophilic ligands that thereby modulate innate immune responses. To our knowledge, this is the first study reporting the binding of Siglecs to lipid ligands, expanding our understanding of the biological function and importance of Siglecs in the innate immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.